Table of Contents
Executive Summary
5
SWOT Analysis6
China Pharmaceuticals And Healthcare Industry SWOT 6
China Political SWOT 7
China Economic SWOT 8
China Business Environment SWOT 9
Pharmaceutical Business Environment Ratings 10
Table: Asia Pacific Pharmaceuticals & Healthcare Business Environment Rankings For Q209 10
Limits of Potential Returns 11
Risks to Realisation of Returns 11
Market Summary 12
Regulatory Regime13
Intellectual Property Issues 13
Counterfeit Activities 15
Pricing and Reimbursement 16
Advertising Sector 18
SFDA Scandal 19
Other Regulatory Developments 21
Industry Trends and Developments24
Healthcare Sector 24
Hospital Sector 25
Epidemiology 27
Distribution Sector 30
Table: Top Ten Chinese Pharmaceutical Distributors In 2007 31
Traditional Chinese Medicines 32
R&D Activity 32
Vaccine Sector 34
Clinical Trials Activity 36
Biotechnology Sector 37
Active Pharmaceutical Ingredients (APIs) 38
Pharmaceutical Equipment Sector 40
Industry Forecast Scenario 41
Overall Market Forecast 41
Table: China - Drug Market Data And Forecasts, 2003-2013 42
Table: Macroeconomic Indicators Used In BMI' s Pharmaceutical Market Expenditure Model, 2003-2013 42
Key Growth Factors - Industry 43
Table: China - Health Expenditure Data And Forecasts, 2003-2013 44
Key Growth Factors - Macroeconomic 45
Table: China - Economic Activity, 2006-2013 47
Prescription Market Forecast 48
Table: China - Prescription Drug Market Data And Forecasts (CNYmn unless otherwise stated) 49
OTC Market Forecast 50
Table: China - OTC Market Data And Forecasts (US$mn unless otherwise stated) 51
Generics and Patented Market Forecasts 52
Table: China - Generics And Patented Market Forecasts, 2003-2013 53
Export/Import Forecasts 54
Table: China - Pharmaceutical Trade Data And Forecasts, 2003-2013 (US$mn) 55
Medical Device Market Forecast 56
China: Medical Device Market Data And Forecasts, 2006-2012 (US$bn unless otherwise stated) 58
Other Healthcare Data Forecasts 59
Table: China - Hospital Data Forecasts, 2005-2013 59
Key Risks to BMI' s Forecast Scenario 60
Competitive Landscape61
Top Ten Chinese Pharmaceutical Companies In 2007 62
Table: Top 10 OTC Companies In China By 2006 Sales 62
Top Ten Chinese Retail Pharmacy Chains In 2007 63
Company Profiles64
Leading Multinational Companies 64
GlaxoSmithKline 64
Pfizer 66
AstraZeneca 68
Merck KGaA 71
Sanofi-Aventis 73
Novartis 75
Roche 78
Merck & Co 80
Bayer Schering Pharma 82
Indigenous Manufacturers 85
North China Pharmaceutical Group Corporation (NCPC) 85
China Biopharmaceuticals Holdings (CBH) 87
Hubei Biocause Heilen Pharmaceutical 89
Aida Pharmaceutical Holdings 91
Country Snapshot: China Demographic Data93
Section 1: Population 93
Table: Demographic Indicators, 2005-2030 93
Table: Rural/Urban Breakdown, 2005-2030 94
Section 2: Education and Healthcare 94
Table: Education, 2002-2005 94
Table: Vital Statistics, 2005-2030 94
BMI Forecast Modelling95
How We Generate Our Pharmaceutical Industry Forecasts 95
Pharmaceutical Business Environment Ratings Methodology 96
Ratings Overview 96
Table: Pharmaceutical Business Environment Indicators 97
Weighting 98
Table: Weighting Of Components 98
Sources 98
| 
View Cart
